Novavax outlines $230M–$270M 2026 revenue target with new Pfizer partnership and cost reduction strategy
Earnings Call Insights: Novavax, Inc. (NVAX) Q4 2025 Management View John Jacobs, President and CEO, stated that "we made significant progress on our corporate strategy in 2025, successfully executing against our existing partnerships while advancing...
Seeking Alpha